
New Bill Would Guarantee Medicare Coverage of Newly Approved Breakthrough Devices
Congress brings back controversial Trump plan scrapped by the Biden administration.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LABORATORY INDUSTRY REPORT
NATIONAL LAB REPORTER
Congress brings back controversial Trump plan scrapped by the Biden administration.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
On March 28, the 118th Congress raised lab industry hopes once more by reintroducing the Saving Access to Laboratory Services Act (SALSA).
It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.
The bipartisan bill was recently reintroduced to amend the FCA in response to a landmark 2016 Supreme Court ruling.